FDA Panel Endorses Broader Use of Certain Peptides in Treatment of Various Conditions
The FDA advisory panel recommended that compounding pharmacies be allowed to manufacture certain peptides, including BPC-157 and KPV, after a narrow vote.
Synthesized news with full source attribution.
The FDA advisory panel recommended that compounding pharmacies be allowed to manufacture certain peptides, including BPC-157 and KPV, after a narrow vote.